Progressive Care, Inc.
RXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.09 | -0.00 | 0.06 |
| FCF Yield | 31.09% | -18.62% | 4.07% | -2.45% |
| EV / EBITDA | -0.33 | 15.13 | -0.91 | -33.22 |
| Quality | ||||
| ROIC | 2.64% | -0.95% | 2.11% | -4.67% |
| Gross Margin | 12.93% | 7.31% | 12.51% | 30.59% |
| Cash Conversion Ratio | -0.33 | 6.12 | -0.07 | 0.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.42% | 10.46% | 8.57% | 5.31% |
| Free Cash Flow Growth | 232.38% | -389.49% | 230.37% | 31.71% |
| Safety | ||||
| Net Debt / EBITDA | 0.82 | -7.13 | 0.43 | 9.06 |
| Interest Coverage | 29.00 | -16.56 | 37.89 | -35.49 |
| Efficiency | ||||
| Inventory Turnover | 5.01 | 4.01 | 4.11 | 2.85 |
| Cash Conversion Cycle | 10.40 | 25.94 | 5.17 | -11.88 |